ASH 2021

Disparities in outcomes for patients with multiple myeloma have been linked to socioeconomic barriers. This study, published in Leukemia Research, aimed to provide further insight into the nature of these disparities to ensure equitable treatment. Specifically, the study focuses on the association between insurance status and survival in patients with multiple myeloma. This study relied...

The use of HSCT for sickle cell disease is evolving, and no randomized controlled trials were identified in the evidence review for this guideline In a 2021 clinical guideline issued by the American Society of Hematology and published online Sept. 28 in Blood Advances, eight conditional recommendations are presented for the use of hematopoietic stem...